Louis Sloan
- Infectious Diseases top 5%
- Virology top 1%
- Emergency Medicine top 5%
- Immunology
- Epidemiology
- Co-authors
- Edwin DeJesusMark S. ShaeferPrincy KumarDerek M. FineSherene MinParul PatelPaul WannamakerTamio Fujiwara
- Topics
- HIV Research and Treatment (14 papers)HIV/AIDS drug development and treatment (9 papers)Immunotherapy and Immune Responses (5 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Louis Sloan
18 papers receiving 699 citations
Peers
Comparison fields: 5 of 69
- Infectious Diseases 545
- Virology 431
- Emergency Medicine 190
- Immunology 129
- Epidemiology 111
Countries citing papers authored by Louis Sloan
This map shows the geographic impact of Louis Sloan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Sloan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Sloan more than expected).
Fields of papers citing papers by Louis Sloan
This network shows the impact of papers produced by Louis Sloan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Sloan. The network helps show where Louis Sloan may publish in the future.
Co-authorship network of co-authors of Louis Sloan
This figure shows the co-authorship network connecting the top 25 collaborators of Louis Sloan. A scholar is included among the top collaborators of Louis Sloan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Sloan. Louis Sloan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 88 | |
| 3 | 2 | |
| 4 | 35 | |
| 5 | 14 | |
| 6 | 17 | |
| 7 | 171 | |
| 8 | 15 | |
| 9 | 38 | |
| 10 | 10 | |
| 11 | 17 | |
| 12 | 1 | |
| 13 | 108 | |
| 14 | 167 | |
| 15 | Comparable Safety and Effi cacy With Once-daily (QD) Versus Twice-daily (BID) Dosing of Lopinavir/ritonavir (LPV/r) Tablets With Emtricitabine (FTC) + Tenofovir DF (TDF) in Antiretroviral (ARV)-naïve, HIV-1-infected Subjects: 96-Week Results of the Randomized Trial M05-730 | 1 |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 21 |
About Louis Sloan
Louis Sloan is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 18 papers that have together received 717 indexed citations. Recurring topics across this work include HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (9 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Virology (431 citations), Infectious Diseases (545 citations) and Emergency Medicine (190 citations). Louis Sloan has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Edwin DeJesus, Mark S. Shaefer, Princy Kumar, Derek M. Fine, Sherene Min, Parul Patel, Paul Wannamaker, Tamio Fujiwara, Ivy Song and Cindy Vavro. Their work appears in journals such as European Journal of Immunology, AIDS and Journal of Immunological Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.